12 Month Price Forecast For BIOX
Distance to BIOX Price Forecasts
BIOX Price Momentum
🤔 Considering Bioceres (BIOX)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 23, 2025 3:31 AM UTC
BIOX Analyst Ratings & Price Targets
Based on our analysis of 7 Wall Street analysts, BIOX has a consensus that is bullish. The median price target is $13.00, with forecasts ranging from $9.50 to $13.00. Currently, there are 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
With BIOX currently trading at $7.01, the median price forecast suggests a 85.6% upside. The most optimistic forecast comes from Kristen Owen at Oppenheimer, projecting a 85.6% upside, while Austin Moeller at Canaccord Genuity provides the most conservative target, suggesting a 35.6% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
BIOX Analyst Consensus
BIOX Price Target Range
Latest BIOX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for BIOX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 13, 2024 | Canaccord Genuity | Austin Moeller | Buy | Maintains | $9.50 |
| Oct 21, 2024 | Oppenheimer | Kristen Owen | Outperform | Maintains | $13.00 |
| Oct 17, 2024 | Canaccord Genuity | Austin Moeller | Buy | Maintains | $10.00 |
| Sep 11, 2024 | Roth MKM | Scott Fortune | Buy | Maintains | $13.00 |
| Sep 11, 2024 | Oppenheimer | Kristen Owen | Outperform | Maintains | $16.00 |
| Sep 11, 2024 | Lake Street | Ben Klieve | Buy | Maintains | $13.00 |
| Sep 11, 2024 | Canaccord Genuity | Austin Moeller | Buy | Maintains | $12.50 |
| Jul 19, 2024 | Canaccord Genuity | Austin Moeller | Buy | Assumes | $17.00 |
| Jul 2, 2024 | Roth MKM | Scott Fortune | Buy | Reinstates | $15.00 |
| Feb 9, 2024 | Roth MKM | Brian Wright | Buy | Maintains | $21.00 |
| Nov 1, 2023 | Roth MKM | Brian Wright | Buy | Maintains | $20.00 |
| Sep 12, 2023 | Lake Street | Ben Klieve | Buy | Maintains | $25.00 |
| Sep 12, 2023 | Roth MKM | Brian Wright | Buy | Reiterates | $31.00 |
| Aug 16, 2023 | Roth MKM | Buy | Reiterates | $0.00 | |
| Apr 6, 2023 | Oppenheimer | Kristen Owen | Outperform | Initiates | $15.00 |
| Sep 30, 2022 | Canaccord Genuity | Bobby Burleson | Buy | Initiates | $22.50 |
| Oct 8, 2021 | Roth Capital | Brian Wright | Buy | Initiates | $21.00 |
| Mar 15, 2021 | Lake Street | Buy | Initiates | $0.00 |
Stocks Similar to Bioceres Crop Solutions Corp
The following stocks are similar to Bioceres based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Bioceres Crop Solutions Corp (BIOX) Financial Data
Bioceres Crop Solutions Corp has a market capitalization of $436.47M with a P/E ratio of 361.0x. The company generates $441.23M in trailing twelve-month revenue with a 0.6% profit margin.
Revenue growth is -20.3% quarter-over-quarter, while maintaining an operating margin of +4.3% and return on equity of +1.1%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Bioceres Crop Solutions Corp (BIOX) Company Overview
About Bioceres Crop Solutions Corp
Provides crop productivity solutions.
The company operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. It generates revenue by offering a range of products, including high-yield seeds, crop protection chemicals, and nutritional inputs for crops, catering to agricultural markets across multiple regions.
Founded in 2001 and headquartered in Rosario, Argentina, the company has a strong international presence, serving markets in Argentina, Brazil, North America, Europe, the Middle East, and South America. Its innovative HB4 drought-tolerant seed technology program highlights its focus on sustainable agriculture.
Company Information
Sector
Basic Materials
Industry
Agricultural Inputs
Employees
0
CEO
Dr. Federico Trucco Ph.D.
Country
Argentina
IPO Year
N/A
Bioceres Crop Solutions Corp (BIOX) Latest News & Analysis
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) will hold its Q1 2025 earnings conference call on November 12, 2024, at 8:30 AM ET, featuring key company executives and analysts.
The call will reveal Bioceres' Q1 2025 financial performance and strategic direction, influencing market sentiment and stock valuations. Key insights may impact investment decisions.
Bioceres reported challenging 1Q25 results due to adverse weather, impacting crop sectors. Shares are down to $6.7 with a $400M market cap; caution advised amid financial risks and underwhelming HB4 sales.
Bioceres' challenging 1Q25 results due to weather impact stock performance, with a significant share price drop. Caution is advised as recovery potential exists, but financial risks remain.
Bioceres Crop Solutions Reports Fiscal First Quarter 2025 Financial and Operational Results
2 months agoBioceres Crop Solutions Corp. (NASDAQ: BIOX) reported its fiscal Q1 financial results for the period ending September 30, 2024, in accordance with International Financial Reporting Standards.
Bioceres' financial results indicate its performance and growth in the agricultural sector, which can influence stock valuation and investor sentiment amid climate resilience trends.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will hold a conference call on November 12, 2024, at 8:30 a.m. ET to discuss Q1 fiscal results ending September 30, 2024.
Bioceres' upcoming earnings call could reveal insights into its financial health and growth potential, impacting stock performance and investor sentiment in the agricultural sector.
Retail investors often follow momentum and trends in stock discussions, which can influence their investment decisions, though timing the market remains a challenge.
Retail investors often follow trends and momentum, impacting stock demand. Popular stocks can see increased volatility, influencing investment strategies and potential returns.
The materials sector has identified oversold stocks, indicating potential buying opportunities for undervalued companies.
Oversold stocks in the materials sector indicate potential price recovery, offering investors a chance to acquire undervalued assets for future gains.
Frequently Asked Questions About BIOX Stock
What is Bioceres Crop Solutions Corp's (BIOX) stock forecast for 2025?
Based on our analysis of 7 Wall Street analysts, Bioceres Crop Solutions Corp (BIOX) has a median price target of $13.00. The highest price target is $13.00 and the lowest is $9.50.
Is BIOX stock a good investment in 2025?
According to current analyst ratings, BIOX has 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $7.01. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for BIOX stock?
Wall Street analysts predict BIOX stock could reach $13.00 in the next 12 months. This represents a 85.6% increase from the current price of $7.01. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Bioceres Crop Solutions Corp's business model?
The company operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. It generates revenue by offering a range of products, including high-yield seeds, crop protection chemicals, and nutritional inputs for crops, catering to agricultural markets across multiple regions.
What is the highest forecasted price for BIOX Bioceres Crop Solutions Corp?
The highest price target for BIOX is $13.00 from Kristen Owen at Oppenheimer, which represents a 85.6% increase from the current price of $7.01.
What is the lowest forecasted price for BIOX Bioceres Crop Solutions Corp?
The lowest price target for BIOX is $9.50 from Austin Moeller at Canaccord Genuity, which represents a 35.6% increase from the current price of $7.01.
What is the overall BIOX consensus from analysts for Bioceres Crop Solutions Corp?
The overall analyst consensus for BIOX is bullish. Out of 7 Wall Street analysts, 4 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $13.00.
How accurate are BIOX stock price projections?
Stock price projections, including those for Bioceres Crop Solutions Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
